Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

365 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Localization of heparanase in normal and pathological human placenta.
Haimov-Kochman R, Friedmann Y, Prus D, Goldman-Wohl DS, Greenfield C, Anteby EY, Aviv A, Vlodavsky I, Yagel S. Haimov-Kochman R, et al. Among authors: aviv a. Mol Hum Reprod. 2002 Jun;8(6):566-73. doi: 10.1093/molehr/8.6.566. Mol Hum Reprod. 2002. PMID: 12029075
Expression of heparanase, Mdm2, and erbB2 in ovarian cancer.
Ginath S, Menczer J, Friedmann Y, Aingorn H, Aviv A, Tajima K, Dantes A, Glezerman M, Vlodavsky I, Amsterdam A. Ginath S, et al. Among authors: aviv a. Int J Oncol. 2001 Jun;18(6):1133-44. doi: 10.3892/ijo.18.6.1133. Int J Oncol. 2001. PMID: 11351242
Ibrutinib With Bendamustine and Rituximab for Treatment of Patients With Relapsed/Refractory Aggressive B-Cell Lymphoma.
Kedmi M, Ribakovsy E, Benjamini O, Schiby G, Barshack I, Raskin S, Eshet Y, Mehr R, Horowitz N, Gurion R, Goldschmidt N, Perry C, Levi I, Aviv A, Herzog-Tzarfati K, Nagler A, Avigdor A. Kedmi M, et al. Among authors: aviv a. Hematol Oncol. 2024 Nov;42(6):e70001. doi: 10.1002/hon.70001. Hematol Oncol. 2024. PMID: 39572395 Clinical Trial.
Addition of Nivolumab Tailored by Expansion of CAR-T Cells in Patients with Stable/Progressive Large B Cell Lymphoma at Lymphodepletion-A Phase 2, Prospective Interventional Study.
Ram R, Amit O, Perry C, Herishanu Y, Avivi I, Sarid N, Apel A, Preis M, Aviv A, Shapira S, Shragai T, Joffe E, Shargian L, Herzog-Tsarfati K, Eylati N, Acria L, Fridberg G, Gold R, Glait-Santar C, Kay S, Gal-Rabinovich K, Rosenberg D, Setter-Marco N, Beyar-Katz O. Ram R, et al. Among authors: aviv a. Transplant Cell Ther. 2024 Oct 11:S2666-6367(24)00692-4. doi: 10.1016/j.jtct.2024.09.024. Online ahead of print. Transplant Cell Ther. 2024. PMID: 39396632
Clonal landscape and clinical outcomes of telomere biology disorders: somatic rescuing and cancer mutations.
Gutierrez-Rodrigues F, Groarke EM, Thongon N, Rodriguez-Sevilla JJ, Bazzo Catto LF, Niewisch MR, Shalhoub RN, McReynolds LJ, Clé DV, Patel BA, Ma X, Hironaka D, Donaires FS, Spitofsky NR, Santana BA, Lai TP, Alemu L, Kajigaya S, Darden I, Zhou W, Browne PV, Paul S, Lack J, Young DJ, DiNardo CD, Aviv A, Ma F, Michels de Oliveira M, Azambuja AP, Dunbar CE, Olszewska M, Olivier E, Papapetrou EP, Giri N, Alter BP, Bonfim CMS, Wu CO, Garcia-Manero G, Savage SA, Young NS, Colla S, Calado RT. Gutierrez-Rodrigues F, et al. Among authors: aviv a. Blood. 2024 Sep 24:blood.2024025023. doi: 10.1182/blood.2024025023. Online ahead of print. Blood. 2024. PMID: 39316766
365 results